Renin-angiotensin-aldosterone system-blocker-induced angioedema
ORPHA: 100057
Overview
Renin-angiotensin-aldosterone system (RAAS)-blocker induced angioedema (RAE) is a type of acquired angioedema (AAE, see this term) characterized by acute edema in subcutaneous tissues, viscera and/or the upper airway
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with Renin-angiotensin-aldosterone system-blocker-induced angioedema, sourced from HPO and Orphanet clinical annotations.
AngioedemaFacial edemaAbnormal capillary physiologyRespiratory distressSwollen lipTongue edemaPalpebral edemaUpper airway obstructionErythemaPharyngeal edemaLaryngeal edema
Classification & Codes
Orphanet Code
ORPHA:100057Renin-angiotensin-aldosterone system-blocker-induced angioedema
| Orphanet | ORPHA:100057 |
| Treatments | 0 drug(s) |
| Symptoms on record | 11 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO